About Nicholas Tritos, MD, DSC
Dr. Tritos is a staff neuroendocrinologist in the Neuroendocrine and Pituitary Tumor Clinical Center and a faculty member in the Neuroendocrine Unit at the Massachusetts General Hospital. He serves as an Associate Professor of Medicine at Harvard Medical School. He also conducts clinical research with a focus on pituitary tumors and growth hormone deficiency in adults. He is the author or co-author of more than 130 peer-reviewed publications in endocrinology, and an associate editor, editorial board member and regular peer-reviewer for professional journals. He has been regularly serving on professional and scientific committees (Endocrine Society, Pituitary Society and AACE).
Clinical Interests:
- Acromegaly
- Adult Growth Hormone Deficiency
- Cushing's syndrome
- Hypopituitarism
- Pituitary disease
- Pituitary tumors
- Prolactinomas
- Thyrotropinoma
Treats:
- Adult
Languages:
- French, Greek
Locations
Mass General Endocrinology: Neuroendocrine & Pituitary Tumor Clinical Center
55 Fruit St.
Boston, MA 02114
Phone: 617-726-7948
Medical Education
- MD, University of Athens School of Medicine
- Residency, New England Deaconess Hospital
- Fellowship, Beth Israel Deaconess Medical Center
American Board Certifications
- Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Centene/Celticare
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- Mass General Brigham Health Plan - ACD
- Mass General Brigham Health Plan - PBO
- MassHealth
- Medicare
- Medicare - ACD
- Medicare ACO - ACD
- Medicare ACO - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Tritos conducts clinical research with a focus on pituitary tumors and growth hormone deficiency in adults. He is the author or co-author of more than 130 peer-reviewed publications in the field of endocrinology, associate editor, editorial board member and a regular peer-reviewer for professional Journals.
Publications
-
N.A. Tritos, P.W. Schaefer, T.D. Stein. Case records of the Massachusetts General Hospital. A 52 year old man with weakness, infections, and enlarged adrenal glands. NEJM 2011; 365: 2520-2530.
N.A. Tritos, S.L. Greenspan, D. King, A. Hamrahian, D.M. Cook, P.J. Jönsson, M.P. Wajnrajch, Maria Koltowska – Häggstrom, B.M.K. Biller. Unreplaced sex steroid deficiency, corticotropin deficiency and lower IGF-1 are associated with lower bone mineral density in adults with growth hormone deficiency. JCEM 2011; 96: 1516- 1523.P.B. Silva PB, F.G. Amlashi, E.W. Yu, K.J. Pulaski-Liebert, A.V. Gerweck, P.K. Fazeli, E. Lawson, L.B. Nachtigall, B.M.K. Biller, K.K. Miller, A. Klibanski, M. Bouxsein, N.A. Tritos. Bone microarchitecture and estimated bone strength in men with active acromegaly. EJE 2017; 177: 409-420.
N. Qiao, B. Swearingen, N.A. Tritos. Cushing's disease in older adults: presentation and outcome. Clin Endocrinol 2018; 89: 444-453.
B.P. Galm, E.L. Martinez-Salazar, B. Swearingen, M. Torriani, A. Klibanski, M.A. Bredella, N.A. Tritos. MRI texture analysis as a predictor of tumor recurrence or progression in patients with clinically non-functioning pituitary adenomas. EJE 2018; 191-198.
A. Faje, K. Reynolds, L. Zubiri, D. Lawrence, J. Cohen, R. Sullivan, L. Nachtigall, N.A. Tritos. Hypophysitis secondary to nivolumab and pembrolizumab is distinct from ipilimumab-associated hypophysitis. EJE 2019 Jun 1. pii: EJE-19-0238.R1. doi: 10.1530/EJE-19-0238.
B.P. Galm, N. Qiao, A. Klibanski, B.M.K. Biller, N.A. Tritos. Accuracy of laboratory tests for the diagnosis of Cushing's syndrome. JCEM 2020; 105: 2081-2094.